Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity

Clinical trial NCT00845338 · TERMINATED

Trial details

NCT number: NCT00845338
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis Overactive Detrusor

Start date: 2007-02-01
Primary completion: 2007-10-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.